跳至主要内容
临床试验/NCT04977596
NCT04977596已完成不适用

Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
78
试验地点
1
主要终点
Margin

研究概览

简要总结

  1. Imaging findings (including CT and MRI images) of both well-differentiated G3 PNET and poorly differentiated PNET were studied;
  2. The CT imaging findings of G3 stage PNET and pancreatic cancer were compared to establish a Logistic regression diagnostic model, and the survival analysis of the two was compared.
  3. Cox regression was used to study the risk factors for survival prognosis of well-differentiated and poorly differentiated PNET based on CT image features

详细描述

According to the latest WHO Classification of Neuroendocrine Neoplasms (NET) in 2019, pancreatic neuroendocrine neoplasms (PNET) are divided into well-differentiated and poorly differentiated PNETs.The former is divided into G1, G2, and well differentiated G3.There are few studies on the survival outcomes of these two differentiated PNET types.The G3 imaging manifestations of the two types of differentiation have not been studied yet, and G3 PNET is often clinically misdiagnosed as pancreatic cancer, so it is necessary to differentiate the imaging manifestations and survival time of the two types.

A total of 71 patients with PNET in our hospital from January 2012 to January 2019 and 58 patients with pancreatic cancer from February 2014 to August 2015 were retrospectively collected. Complete survival time data of all patients after telephone follow-up were obtained.Since G3 PNET is very rare, the investigators enrolled 9 patients with G3 PNET in the First Affiliated Hospital of Zhejiang University School of Medicine and 7 patients with G3 PNET in the Affiliated Hospital of Air Force Military Medical University from January 2013 to October 2018.

CT images of PNET and pancreatic cancer were analyzed independently by two radiologists specializing in abdominal diagnosis, in which G3 lesions were evaluated simultaneously on MRI images and the others were evaluated only on CT images.Records clinical data and imaging characteristics: gender, age, tumor markers, tumor shape, size, tumor characteristics, edge, the expansion of the shrinking, pancreas, pancreatic pancreatitis, enhancement scan, arterial phase and portal phase lesions and the ratio of pancreatic parenchyma around, liver metastasis, peripheral vascular invasion, lymph node metastasis.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis by pathology and detailed pathological information
  • Enhanced CT examination or biopsy were performed within 2 months before surgery
  • There was no preoperative radiotherapy or chemotherapy

排除标准

  • No Ki-67 index
  • CT value cannot be measured by ROI because of pancreatic atrophy and other reasons
  • No enhanced images or missing images

结局指标

主要结局

Margin

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

well-defined or ill-defined

tumor texture

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

solid;solid and cystic;complex cystic

CT value of pancreas plain scan

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

CT value of pancreas plain scan

CT value of pancreas portal phase

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

CT value of pancreas portal phase

CT value of lesion artery phase

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

CT value of lesion artery phase

CT value of lesion portal phase

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

CT value of lesion portal phase

Pancreatic tail contraction

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

yes or no

Complicated pancreatitis

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

yes or no

Pancreatic duct/bile duct dilatation

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

yes or no

CT value of lesion plain scan

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

CT value of lesion plain scan

Tumor size

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

Maximum surface size of the lesion (cm)

Tumor location

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

Locations of the pancreas: head, neck, body and tail

Number of lesions

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

Number of lesions

Extrapancreatic tissue invasion

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

yes or no

Hepatic metastasis

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

yes or no

Lymphatic metastasis

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

yes or no

CT value of pancreas artery phase

时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy

CT value of pancreas artery phase

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验